Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15998 participants
INTERVENTIONAL
2021-06-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This trial aims to study whether the implantation of the EWS in a regional hospital reduces the mean hospital stay (primary objective), mortality and complications (secondary objectives).
For this, an open clinical trial will be carried out in which the hospitalization floors of the hospital will be administratively divided into two sections (two study branches); the EWS scale will be implemented in the computer equipment of one of the sections of each floor, acting the another section as a control branch.
All the patients admitted to the participating hospital floors during one year will be included in the study. The mean stay, mortality and complications will be compared between study branches.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of an Early Warning Score for Detecting the Deterioration of a Patients' General Condition in an Acute Hospital
NCT05639452
Correlation Between Monitoring Frequency and Clinical Deterioration in Hospitalized Patients
NCT02180854
Electronically Recorded National Early Warning Scores, Pain Scores and PONV Scores Among Hospitalized Patients
NCT04055350
Develop, Implement and Assess Effectiveness of Early Warning Score (EWS) for Moneragala District General Hospital
NCT02523456
Scoring Model for Predicting Outcome in Patients With Cardiogenic Shock
NCT04850248
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EWS
Early Warning Score will be implemented in the computer system of the nursing station
EWS
Early Warning Score will be implemented in the computer system of the nursing station which belong to this intervention group. When the nurses enter the vital signs of the patients into the system, the EWS will be automatically calculated and an alarm will be displayed if an intervention is necessary, which is protocolized.
Control
Nursing supervision will be carried out in the usual way.
usual clinical care
Nurses perform their clinical monitoring activities as usual. EWS will not be implemented in their nursing station
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EWS
Early Warning Score will be implemented in the computer system of the nursing station which belong to this intervention group. When the nurses enter the vital signs of the patients into the system, the EWS will be automatically calculated and an alarm will be displayed if an intervention is necessary, which is protocolized.
usual clinical care
Nurses perform their clinical monitoring activities as usual. EWS will not be implemented in their nursing station
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Consorci Sanitari de l'Alt Penedès i Garraf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cristina Ramos, Nurse
Role: PRINCIPAL_INVESTIGATOR
CSAPG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Consorci Sanitari de l'Alt Penedès i Garraf
Vilafranca del Penedès, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSAPG-11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.